EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

REGULATORY LANDSCAPE FOR AI IN HEALTHCARE - A COMPREHENSIVE REVIEW

Hemanth Adari*

ABSTRACT

The regulatory landscape for Artificial Intelligence (AI) in healthcare is rapidly evolving, presenting a complex tapestry of challenges and opportunities. This comprehensive review examines the current regulatory frameworks governing the use of AI in healthcare, shedding light on key considerations and emerging trends. The analysis encompasses the regulatory approaches of prominent bodies such as the FDA in the United States and the European Medicines Agency (EMA), while also exploring regulatory landscapes in other critical regions. The review delves into challenges related to standardization, technological advancements, and ethical concerns, providing insights into the opportunities for regulators to adapt and innovate. By offering a thorough exploration of the regulatory dynamics, this review aims to contribute to the understanding and advancement of responsible AI deployment in the healthcare domain.

Keywords: Artificial Intelligence, Healthcare, Regulation, FDA, EMA, Standardization, Technological Advancements, Ethical Concerns, Innovation, Regulatory Frameworks.

[Full Text Article] [Download Certificate]